EHA 2021 | Patient preferences in myeloma, a qualitative multinational study in myelomaConferences, Myeloma11 June 2021
Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlightsAL amyloidosis, Conferences, MPE, Myeloma, Videos18 December 2020
ASH 2020 | Data on Real World Evidence (RWE) on AL amyloidosisAL amyloidosis, Conferences10 December 2020
ASH 2020 | Certain people with blood cancers and COVID-19 infection vulnerable to severe illnessAL amyloidosis, Conferences, Myeloma6 December 2020
ASH 2020 | The phase III trial Apollo supports administering daratumumab subcutaneously instead of intravenously in relapsed or refractory myeloma patientsConferences, Myeloma5 December 2020
